Genome wide expression profiling of the mesodiencephalic region identifies novel factors involved in early and late dopaminergic development
- Koushik Chakrabarty1,*,
- Lars Von Oerthel1,2,*,
- Anita Hellemons1,
- Frédéric Clotman3,
- Agnès Espana3,*,
- Marian Groot Koerkamp4,
- Frank C. P. Holstege4,
- R. Jeroen Pasterkamp1,*,‡ and
- Marten P. Smidt1,2,*,‡
- 1Department of Neuroscience and Pharmacology, Rudolf Magnus Institute of Neuroscience, University Medical Center Utrecht, 3584 CG Utrecht, The Netherlands
- 2Molecular Neuroscience, Swammerdam Institute for Life Sciences, University of Amsterdam, Science Park 904, 1098 XH Amsterdam, The Netherlands
- 3Université Catholique de Louvain, Institute of Neuroscience, Laboratory of Neural Differentiation, Avenue Hippocrate 55, Box B1.55.11, Brussels, B-1200, Belgium
- 4Microarray Facility, Molecular Cancer Research, UMC Utrecht, 3508 AB Utrecht, The Netherlands
- ↵‡Authors for correspondence (r.j.pasterkamp{at}umcutrecht.nl; m.p.smidt{at}uva.nl)
-
↵* These authors contributed equally to this work
Summary
Meso-diencephalic dopaminergic (mdDA) neurons are critical for motor control and cognitive functioning and their loss or dysfunction is associated with disorders such as Parkinson's disease (PD), schizophrenia and addiction. However, relatively little is known about the molecular mechanisms underlying mdDA neuron development and maintenance. Here, we determined the spatiotemporal map of genes involved in the development of mdDA neurons to gain further insight into their molecular programming. Genome-wide gene expression profiles of the developing ventral mesencephalon (VM) were compared at different developmental stages leading to the identification of novel regulatory roles of neuronal signaling through nicotinic acthylcholine receptors (Chrna6 and Chrnb3 subunits) and the identification of novel transcription factors (Oc2 and 3) involved in the generation of the mdDA neuronal field. We show here that Pitx3, in cooperation with Nurr1, is the critical component in the activation of the Chrna6 and Chrnb3 subunits in mdDA neurons. Furthermore, we provide evidence of two divergent regulatory pathways resulting in the expression of Chrna6 and Chrnb3 respectively.
Footnotes
-
Competing interests The authors declare that there are no competing interests.
- © 2012. Published by The Company of Biologists Ltd
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial Share Alike License (http://creativecommons.org/licenses/by-nc-sa/3.0/).













